You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Pegaspargase for treating acute lymphoblastic leukaemia

  • Technology appraisal guidance
  • Reference number: TA408
  • Published:  28 September 2016
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Expected publication
  2. Final appraisal determination
  3. Draft scope documents
  4. Invitation to participate

History

Documents created during the development process.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 179 KB)

    Published:
    28 September 2016

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 318 KB)

    Published:
    27 July 2016
  • Committee papers (PDF 7.44 MB)

    Published:
    27 July 2016
  • Committee papers Committee presentations (PDF 770 KB)

    Published:
    27 July 2016

Draft scope documents

  • Draft scope (pre-referral) (PDF 137 KB)

    Published:
    29 January 2016
  • Provisional matrix (pre-referral) (PDF 101 KB)

    Published:
    29 January 2016

Invitation to participate

  • Final scope (PDF 102 KB)

    Published:
    12 February 2016
  • Final matrix (PDF 100 KB)

    Published:
    12 February 2016
  • NICE's response to comments on the draft scope and provisional matrix (PDF 314 KB)

    Published:
    12 February 2016
  • Equality Impact Assessment (Guidance development) (PDF 120 KB)

    Published:
    12 February 2016
Back to top